{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:08:52Z","timestamp":1781690932405,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:00:00Z","timestamp":1509753600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11886-017-0934-y","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T05:53:55Z","timestamp":1509774835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of a Heart Transplant Candidate"],"prefix":"10.1007","volume":"19","author":[{"given":"Sook Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Keun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,4]]},"reference":[{"issue":"10","key":"934_CR1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","volume":"32","author":"LH Lund","year":"2013","unstructured":"Lund LH, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report\u20142013; focus theme: age. J Heart Lung Transplant. 2013;32(10):951\u201364.","journal-title":"J Heart Lung Transplant"},{"issue":"16","key":"934_CR2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810\u201352.","journal-title":"Circulation"},{"issue":"3","key":"934_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03086123","volume":"16","author":"N Jonge de","year":"2008","unstructured":"de Jonge N, et al. Guidelines for heart transplantation. Neth Heart J. 2008;16(3):79\u201387.","journal-title":"Neth Heart J"},{"issue":"2","key":"934_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1586\/erc.12.186","volume":"11","author":"MP Kinkhabwala","year":"2013","unstructured":"\u2022 Kinkhabwala MP, Mancini D. Patient selection for cardiac transplant in 2012. Expert Rev Cardiovasc Ther. 2013;11(2):179\u201391. This article comprehensively reviews on the patient selection for cardiac transplantation.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"934_CR5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","volume":"83","author":"DM Mancini","year":"1991","unstructured":"\u2022\u2022 Mancini DM, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83(3):778\u201386. This study is the original paper on the value of peak exercise oxygen consumption on the prognosis of advanced heart failure patients.","journal-title":"Circulation"},{"issue":"12","key":"934_CR6","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","volume":"95","author":"KD Aaronson","year":"1997","unstructured":"Aaronson KD, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95(12):2660\u20137.","journal-title":"Circulation"},{"issue":"7","key":"934_CR7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.amjcard.2008.12.010","volume":"103","author":"MN Parikh","year":"2009","unstructured":"Parikh MN, et al. Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >\u00a065 years of age with heart failure. Am J Cardiol. 2009;103(7):998\u20131002.","journal-title":"Am J Cardiol"},{"issue":"3","key":"934_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjcard.2006.08.046","volume":"99","author":"P Green","year":"2007","unstructured":"Green P, Lund LH, Mancini D. Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. Am J Cardiol. 2007;99(3):399\u2013403.","journal-title":"Am J Cardiol"},{"issue":"12","key":"934_CR9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.healun.2003.10.002","volume":"23","author":"TM Koelling","year":"2004","unstructured":"Koelling TM, Joseph S, Aaronson KD. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant. 2004;23(12):1414\u201322.","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"934_CR10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1053-2498(02)01225-1","volume":"22","author":"LR Peterson","year":"2003","unstructured":"Peterson LR, et al. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J Heart Lung Transplant. 2003;22(10):1141\u20138.","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"934_CR11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113(11):1424\u201333.","journal-title":"Circulation"},{"issue":"11","key":"934_CR12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.healun.2011.05.012","volume":"30","author":"A Goda","year":"2011","unstructured":"Goda A, et al. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM). J Heart Lung Transplant. 2011;30(11):1236\u201343.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"934_CR13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.athoracsur.2011.04.030","volume":"92","author":"ES Weiss","year":"2011","unstructured":"Weiss ES, et al. Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg. 2011;92(3):914\u201321. discussion 921-2","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"934_CR14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.healun.2013.02.001","volume":"32","author":"A Kilic","year":"2013","unstructured":"Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. J Heart Lung Transplant. 2013;32(5):492\u20138.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"934_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","volume":"35","author":"MR Mehra","year":"2016","unstructured":"\u2022\u2022 Mehra MR, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1\u201323. This article is the recently updated ISHLT recommendation on the listing criteria for heart transplantation.","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"934_CR16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.healun.2009.08.014","volume":"28","author":"DO Taylor","year":"2009","unstructured":"Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report\u20142009. J Heart Lung Transplant. 2009;28(10):1007\u201322.","journal-title":"J Heart Lung Transplant"},{"issue":"14 Suppl","key":"934_CR17","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1161\/CIRCULATIONAHA.107.756866","volume":"118","author":"ND Patel","year":"2008","unstructured":"Patel ND, et al. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. Circulation. 2008;118(14 Suppl):S83\u20138.","journal-title":"Circulation"},{"issue":"1","key":"934_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","volume":"19","author":"A Costard-Jackle","year":"1992","unstructured":"Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19(1):48\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"934_CR19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/euhj.1998.1155","volume":"20","author":"B Lindelow","year":"1999","unstructured":"Lindelow B, et al. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. Eur Heart J. 1999;20(2):148\u201356.","journal-title":"Eur Heart J"},{"issue":"8","key":"934_CR20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2004.07.013","volume":"24","author":"PP Chang","year":"2005","unstructured":"Chang PP, et al. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant. 2005;24(8):998\u20131007.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"934_CR21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","volume":"114","author":"JM Chen","year":"1997","unstructured":"Chen JM, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 1997;114(4):627\u201334.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"934_CR22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","volume":"25","author":"MR Mehra","year":"2006","unstructured":"\u2022 Mehra MR, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20142006. J Heart Lung Transplant. 2006;25(9):1024\u201342. This article is the first ISHLT recommendation on listing criteria for heart transplantation.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"934_CR23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1388-9842(03)00059-X","volume":"5","author":"S Klotz","year":"2003","unstructured":"Klotz S, et al. Reversible pulmonary hypertension in heart transplant candidates\u2014pretransplant evaluation and outcome after orthotopic heart transplantation. Eur J Heart Fail. 2003;5(5):645\u201353.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"934_CR24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ejcts\/ezs102","volume":"42","author":"LS Santo De","year":"2012","unstructured":"De Santo LS, et al. Pulmonary artery hypertension in heart transplant recipients: how much is too much? Eur J Cardiothorac Surg. 2012;42(5):864\u20139. discussion 869-70","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9","key":"934_CR25","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.transproceed.2007.08.077","volume":"39","author":"M Maruszewski","year":"2007","unstructured":"Maruszewski M, et al. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Transplant Proc. 2007;39(9):2850\u20132.","journal-title":"Transplant Proc"},{"issue":"5","key":"934_CR26","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","volume":"83","author":"CD Etz","year":"2007","unstructured":"Etz CD, et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg. 2007;83(5):1697\u2013705.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"934_CR27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2006.08.104","volume":"133","author":"D Zimpfer","year":"2007","unstructured":"Zimpfer D, et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg. 2007;133(3):689\u201395.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"934_CR28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.healun.2006.12.012","volume":"26","author":"S Goland","year":"2007","unstructured":"Goland S, et al. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation. J Heart Lung Transplant. 2007;26(4):312\u20138.","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"934_CR29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","volume":"31","author":"C Ronco","year":"2010","unstructured":"Ronco C, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31(6):703\u201311.","journal-title":"Eur Heart J"},{"issue":"10","key":"934_CR30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","volume":"349","author":"AO Ojo","year":"2003","unstructured":"Ojo AO, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931\u201340.","journal-title":"N Engl J Med"},{"issue":"5","key":"934_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1399-0012.2005.00408.x","volume":"19","author":"Z Aly Al","year":"2005","unstructured":"Al Aly Z, et al. The natural history of renal function following orthotopic heart transplant. Clin Transpl. 2005;19(5):683\u20139.","journal-title":"Clin Transpl"},{"issue":"1","key":"934_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","volume":"22","author":"SM Flechner","year":"2008","unstructured":"Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transpl. 2008;22(1):1\u201315.","journal-title":"Clin Transpl"},{"issue":"9","key":"934_CR33","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","volume":"12","author":"A Zuckermann","year":"2012","unstructured":"Zuckermann A, et al. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant. 2012;12(9):2487\u201397.","journal-title":"Am J Transplant"},{"issue":"6","key":"934_CR34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","volume":"31","author":"L Potena","year":"2012","unstructured":"Potena L, et al. Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study. J Heart Lung Transplant. 2012;31(6):565\u201370.","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"934_CR35","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","volume":"34","author":"M Nikolaou","year":"2013","unstructured":"Nikolaou M, et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2013;34(10):742\u20139.","journal-title":"Eur Heart J"},{"issue":"3","key":"934_CR36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","volume":"14","author":"AP Ambrosy","year":"2012","unstructured":"Ambrosy AP, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012;14(3):302\u201311.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"934_CR37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","volume":"11","author":"LA Allen","year":"2009","unstructured":"Allen LA, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11(2):170\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"934_CR38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1253\/circj.72.364","volume":"72","author":"H Shinagawa","year":"2008","unstructured":"Shinagawa H, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J. 2008;72(3):364\u20139.","journal-title":"Circ J"},{"issue":"2","key":"934_CR39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2362.2011.02573.x","volume":"42","author":"G Poelzl","year":"2012","unstructured":"Poelzl G, et al. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Investig. 2012;42(2):153\u201363.","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"934_CR40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","volume":"16","author":"VM Deursen van","year":"2010","unstructured":"van Deursen VM, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail. 2010;16(1):84\u201390.","journal-title":"J Card Fail"},{"issue":"1","key":"934_CR41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11897-014-0238-0","volume":"12","author":"G Poelzl","year":"2015","unstructured":"Poelzl G, Auer J. Cardiohepatic syndrome. Curr Heart Fail Rep. 2015;12(1):68\u201378.","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"934_CR42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1432-2277.2005.00122.x","volume":"18","author":"W Dichtl","year":"2005","unstructured":"Dichtl W, et al. Cardiac hepatopathy before and after heart transplantation. Transpl Int. 2005;18(6):697\u2013702.","journal-title":"Transpl Int"},{"issue":"6","key":"934_CR43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","volume":"31","author":"A Chokshi","year":"2012","unstructured":"Chokshi A, et al. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant. 2012;31(6):591\u2013600.","journal-title":"J Heart Lung Transplant"},{"issue":"22","key":"934_CR44","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","volume":"61","author":"MS Kim","year":"2013","unstructured":"Kim MS, et al. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013;61(22):2253\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"934_CR45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.healun.2014.12.009","volume":"34","author":"M Farr","year":"2015","unstructured":"Farr M, et al. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transplant. 2015;34(7):873\u201382.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"934_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.healun.2013.10.018","volume":"33","author":"B Chamarthi","year":"2014","unstructured":"Chamarthi B, et al. Impact of pre-diabetes on heart transplant outcomes in patients with advanced heart failure. J Heart Lung Transplant. 2014;33(2):215\u20137.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"934_CR47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1053-2498(02)00567-3","volume":"22","author":"CC Lang","year":"2003","unstructured":"Lang CC, et al. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant. 2003;22(3):244\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"934_CR48","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.jtcvs.2003.11.063","volume":"127","author":"JA Morgan","year":"2004","unstructured":"Morgan JA, et al. Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian. J Thorac Cardiovasc Surg. 2004;127(5):1486\u201392.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"934_CR49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjcard.2016.04.023","volume":"118","author":"S Kumar","year":"2016","unstructured":"Kumar S, et al. Effect of hepatitis C positivity on survival in adult patients undergoing heart transplantation (from the United Network for Organ Sharing Database). Am J Cardiol. 2016;118(1):132\u20137.","journal-title":"Am J Cardiol"},{"issue":"11","key":"934_CR50","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.healun.2011.06.003","volume":"30","author":"I Lee","year":"2011","unstructured":"Lee I, et al. Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity. J Heart Lung Transplant. 2011;30(11):1266\u201374.","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"934_CR51","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00007890-199811270-00015","volume":"66","author":"H Wedemeyer","year":"1998","unstructured":"Wedemeyer H, et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation. 1998;66(10):1347\u201353.","journal-title":"Transplantation"},{"issue":"8","key":"934_CR52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1053-2498(00)00142-X","volume":"19","author":"JD Hosenpud","year":"2000","unstructured":"Hosenpud JD, et al. Outcomes in patients who are hepatitis B surface antigen-positive before transplantation: an analysis and study using the joint ISHLT\/UNOS thoracic registry. J Heart Lung Transplant. 2000;19(8):781\u20135.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"934_CR53","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v22.i4.1650","volume":"22","author":"S Belga","year":"2016","unstructured":"Belga S, Doucette KE. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: a new horizon. World J Gastroenterol. 2016;22(4):1650\u201363.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"934_CR54","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","volume":"48","author":"JM Aguado","year":"2009","unstructured":"Aguado JM, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009;48(9):1276\u201384.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"934_CR55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.healun.2008.11.005","volume":"28","author":"A Jazrawi","year":"2009","unstructured":"Jazrawi A, et al. Tuberculosis in a solid-organ transplant recipient: modern-day implications. J Heart Lung Transplant. 2009;28(2):191\u20133.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"934_CR56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/TP.0000000000001192","volume":"101","author":"SA Acuna","year":"2017","unstructured":"Acuna SA, et al. Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis. Transplantation. 2017;101(3):471\u201381.","journal-title":"Transplantation"},{"issue":"10","key":"934_CR57","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/TP.0b013e318270bc7b","volume":"94","author":"MS Sampaio","year":"2012","unstructured":"Sampaio MS, et al. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation. 2012;94(10):990\u20138.","journal-title":"Transplantation"},{"issue":"10","key":"934_CR58","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00007890-200105270-00021","volume":"71","author":"VM Conraads","year":"2001","unstructured":"Conraads VM, et al. Screening for solid organ malignancies prior to heart transplantation. Transplantation. 2001;71(10):1481\u20133.","journal-title":"Transplantation"},{"issue":"8","key":"934_CR59","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.transproceed.2010.08.012","volume":"42","author":"C Fernandez-Vivancos","year":"2010","unstructured":"Fernandez-Vivancos C, et al. Long-term outcome in heart transplant patients with pretransplant malignancies. Transplant Proc. 2010;42(8):3006\u201310.","journal-title":"Transplant Proc"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-017-0934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:48:32Z","timestamp":1719564512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-017-0934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,4]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s11886-017-0934-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,4]]},"article-number":"133"}}